A similar pattern of expression is observed on malignant B cells, as B-ALL and MM cells were found to be CD37-low or CD37-negative, whereas mature/peripheral B cell leukemias and lymphomas highly express this antigen [224]. This evidence concerns the gene CD37 and Miyoshi myopathy.